128 related articles for article (PubMed ID: 3009672)
1. Effect of inapparent murine hepatitis virus infections on macrophages and host resistance.
Dempsey WL; Smith AL; Morahan PS
J Leukoc Biol; 1986 May; 39(5):559-65. PubMed ID: 3009672
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow derived macrophages have polyamine and ectoenzyme phenotypes distinct from resident macrophages.
Dempsey WL; Hwu P; Russell DH; Morahan PS
Life Sci; 1988; 42(20):2019-27. PubMed ID: 2835568
[TBL] [Abstract][Full Text] [Related]
3. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59.
Wijburg OL; Heemskerk MH; Boog CJ; Van Rooijen N
Immunology; 1997 Oct; 92(2):252-8. PubMed ID: 9415034
[TBL] [Abstract][Full Text] [Related]
4. Role of interferon, antibodies and macrophages in the protective effect of Corynebacterium parvum on encephalomyocarditis virus-induced disease in mice.
Géniteau-Legendre M; Forestier F; Quéro AM; German A
Antiviral Res; 1987 Mar; 7(3):161-7. PubMed ID: 2440381
[TBL] [Abstract][Full Text] [Related]
5. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
[TBL] [Abstract][Full Text] [Related]
6. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
Yang C; Chen Y; Guo G; Li H; Cao D; Xu H; Guo S; Fei L; Yan W; Ning Q; Zheng L; Wu Y
Gut; 2013 Aug; 62(8):1204-13. PubMed ID: 22637698
[TBL] [Abstract][Full Text] [Related]
7. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
Fingerote RJ; Abecassis M; Phillips MJ; Rao YS; Cole EH; Leibowitz J; Levy GA
J Virol; 1996 Jul; 70(7):4275-82. PubMed ID: 8676449
[TBL] [Abstract][Full Text] [Related]
8. Virus specificity of the antiviral state induced by IFN gamma correlates with resistance to MHV 3 infection.
Mello IG; Vassão RC; Pereira CA
Arch Virol; 1993; 132(3-4):281-9. PubMed ID: 7691047
[TBL] [Abstract][Full Text] [Related]
9. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.
Chung S; Gorczynski R; Cruz B; Fingerote R; Skamene E; Perlman S; Leibowitz J; Fung L; Flowers M; Levy G
Immunology; 1994 Nov; 83(3):353-61. PubMed ID: 7835959
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation measured by changes in 5'-nucleotidase and alkaline phosphodiesterase I activities after infection of newborn and juvenile guinea pigs with mycobacterium microti.
Bautista AP; Solomon JB
J Leukoc Biol; 1984 Apr; 35(4):415-26. PubMed ID: 6323604
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in susceptibility of mice to low-virulent mouse hepatitis virus (MHV-2-CC) infection.
Suzuki H; Kiatipattanasakul W; Kajikawa S; Tsutsui S; Nakayama H; Goto N; Doi K
Exp Anim; 1997 Jul; 46(3):211-8. PubMed ID: 9250482
[TBL] [Abstract][Full Text] [Related]
12. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
Yu H; Liu Y; Wang H; Wan X; Huang J; Yan W; Xi D; Luo X; Shen G; Ning Q
Front Immunol; 2018; 9():2935. PubMed ID: 30619295
[No Abstract] [Full Text] [Related]
13. Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro.
Chung S; Sinclair S; Leibowitz J; Skamene E; Fung LS; Levy G
J Immunol; 1991 Jan; 146(1):271-8. PubMed ID: 1701794
[TBL] [Abstract][Full Text] [Related]
14. Stimulatory effects of purified macrophage colony-stimulating factor on murine resident peritoneal macrophages.
Ampel NM; Wing EJ; Waheed A; Shadduck RK
Cell Immunol; 1986 Feb; 97(2):344-56. PubMed ID: 3017577
[TBL] [Abstract][Full Text] [Related]
15. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
16. Changes in macrophage ectoenzymes associated with anti-tumor activity.
Morahan PS; Edelson PJ; Gass K
J Immunol; 1980 Sep; 125(3):1312-7. PubMed ID: 6251133
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the anti-viral mechanism of poly I and poly C against encephalomyocarditis virus infection in the absence of interferon induction in mice.
Stebbing N; Grantham CA; Kaminski F
J Gen Virol; 1976 Jul; 32(1):25-35. PubMed ID: 182913
[TBL] [Abstract][Full Text] [Related]
18. Correlation between growth potential of mouse hepatitis viruses in macrophages and their virulence for mice.
Taguchi F; Yamaguchi R; Makino S; Fujiwara K
Infect Immun; 1981 Dec; 34(3):1059-61. PubMed ID: 6277785
[TBL] [Abstract][Full Text] [Related]
19. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection.
Cervantes-Barragán L; Kalinke U; Züst R; König M; Reizis B; López-Macías C; Thiel V; Ludewig B
J Immunol; 2009 Jan; 182(2):1099-106. PubMed ID: 19124753
[TBL] [Abstract][Full Text] [Related]
20. The significance of T cells, B cells, antibodies and macrophages against encephalomyocarditis (EMC)-D virus-induced diabetes in mice.
Kounoue E; Izumi K; Ogawa S; Kondo S; Katsuta H; Akashi T; Niho Y; Harada M; Tamiya S; Kurisaki H; Nagafuchi S
Arch Virol; 2008; 153(7):1223-31. PubMed ID: 18500429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
